三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
全球用于HTG的临床开发中靶向APOC3的siRNA候选药物
全球用于HTG的临床开发中靶向APOC3的siRNA候选药物
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:153KB
图片尺寸:2268*951
同报告图片
/
4
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
所属报告:
瑞博生物~B-6938.HK-港股公司研究报告:中国小核酸创新药领军者增长潜力大-260409(32页).pdf
打包全文图表
相关数据
靶向PCSK9的siRNA药物研发竞争格局
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
收藏
竞争格局
2026-04-13
原图定位
查看详情
全球用于治疗血栓性疾病的临床开发中的靶向FXI的siRNA候选药物
收藏
行业数据
2026-04-13
原图定位
查看详情
全球已上市的靶向PCSK9治疗HC的siRNA药物
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
收藏
行业数据
2026-04-13
原图定位
查看详情
表7SIRNA、小分子和抗体药物模式的比较
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
收藏
商业模式
2026-03-30
原图定位
查看详情
HTG的药物治疗主要类别
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
收藏
行业数据
2026-03-06
原图定位
查看详情
APOC3及其在动脉粥样硬化中的潜在机制
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
收藏
行业数据
2026-03-06
原图定位
查看详情
全球APOC3小核酸竞争格局
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
收藏
竞争格局
2026-03-06
原图定位
查看详情
靶向ALK7的siRNA药物研发格局
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
收藏
竞争格局
2026-01-14
原图定位
查看详情
全球siRNA药物格局的主要参与者
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
收藏
竞争格局
2026-01-07
原图定位
查看详情
图3、小干扰RNA(siRNA)的作用机制
fCDnu4TliIYv5q2l6aqkICAgICAgIHwg5Yqf6IO9L+aPj+i/sCAgICAgICAgICAgICAgICAgICAgIHwKfC0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCBzaVJOQSAgICAgICAgICAgIHwg5L2c55So6LW35aeL5YiG5a2Q77yM5byV5a+85ZCO57ut5Y+N5bqUICAgICB8CnwgRGljZXIgICAgICAgICAgICB8IOaguOmFuOWGheWIh+mFtu+8jOWPguS4jnNpUk5B5Yqg5belICAgICAgfAp8IFRSQlAgICAgICAgICAgICAgfCDovoXliqnom4vnmb3vvIzkuI5EaWNlcuetieW9ouaIkOWkjeWQiOeJqSAgfAp8IEFHTzIgICAgICAgICAgICAgfCDliIflibJtUk5B77yM5byV5Y+RbVJOQemZjeinoyAgICAgICAgIHwKCui1hOaWmeadpea6kO+8mk1vaGFuIExpdSDnrYnkurosIExhbmRzY2FwZSBvZiBzbWFsbCBudWNsZWljIGFjaWQgdGhlcmFwZXV0aWNzOiBtb3ZpbmcgZnJvbSB0aGU=
收藏
行业数据
2026-01-06
原图定位
查看详情
siRNA国产潜在FIC
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
收藏
行业数据
2025-12-23
原图定位
查看详情
小核酸临床结果统计(上:siRNA疗法;下:AOC疗法)
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
收藏
行业数据
2025-12-23
原图定位
查看详情
四款APOC3药物核心对比(机制、数据、给药、事件终点)
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
收藏
行业数据
2025-11-20
原图定位
查看详情
目前全球针对PCSK9,Lp(a),APOC3三大降血脂靶点的主要临床管线资产及进展
<|begin_of_box|>| 靶点   | 厂家                     | 化学名/研发代号               | 商品名     | 设计机制                                                                 | 首次批准时间/目前最高临床开发阶段                                                                 | 给药方式或频次                     |
|--------|--------------------------|--------------------------------|------------|--------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------|------------------------------------|
| PCSK9  | Amgen                    | evolocumab/依洛尤单抗         | Repatha    | human IgG mAb                                                            | EMA: July 2015 / FDA: Aug 2015<br>NMPA: July 2018                                                  | sc Q2W or Q4W                      |
| PCSK9  | Sanofi/Regeneron         | alirocumab/阿利西尤单抗       | Praluent   | human IgG mAb                                                            | FDA: July 2015 / EMA: Sept 2015<br>NMPA: Jan 2020                                                  | sc Q2W or Q4W                      |
| PCSK9  | Novartis/Alnylam         | Inclisiran/英克司兰            | Leqvio     | RNA interference                                                         | EMA: Dec 2020 / FDA: Dec 2021                                                                     | after 0/3M two inj, Q6M maintainence |
| PCSK9  | Innovent                 | Tafacleimab/托莱西单抗        | 信必乐     | human IgG2 mAb                                                           | NMPA: Aug 2023                                                                                   | sc Q2W or Q4W or Q6W                |
| PCSK9  | MSD                      | MK-0616                       |            | oral macrocyclic peptide                                                 | N/A                                                                                              | daily oral pill                     |
| Lp(a)  | Novartis                 | Pelacarsen/TQJ230/IONIS-APO(a)-LRx |            | GalNac-Lpa ASO                                                           | Ph3 HORIZON(a) trial in patients with established ASCVD                                           | sc Q1M 80mg                        |
| Lp(a)  | Amgen/Arrowhead          | Olpasiran/AMG890              |            | GalNAc-conjugated siRNA                                                  | Ph3 OCEAN(a)-Outcomes trial in patients with established ASCVD                                     | sc Q3M                             |
| Lp(a)  | Eli Lilly/Dicerna        | Lepodisiran/LY3819469         |            | GalNAc-conjugated siRNA                                                  | Ph3 ACCLAIM-Lp(a) in patients with established ASCVD                                              | sc Q6M/Q12M                         |
| Lp(a)  | Eli Lilly                | muvalaplin/LY3473329          |            | oral agent blocking interaction of apo(a) KIV domains 7/8 with the lysine in apoB-100 | Ph2 KRAKEN trial finished                                                                         | 10 mg, 60 mg or 240 mg oral daily   |
| Lp(a)  | Silence Therapeutics     | Zerlasiran/SLN360             |            | 19-mer siRNA                                                             | Ph2 ALPACAR-360 trial                                                                             | sc Q4M/Q6M                          |
| APOC3  | Sirius Therapeutics 靖因药业 | SRSD216                       |            | GalNAc conjugated siRNA                                                  | 2025年第4季度开启全球Ph2                                                                          |                                    |
| APOC3  | CSPC 石药集团            | SYH2068                       |            | GalNAc conjugated siRNA                                                  | 2025年4月开始临床                                                                                 |                                    |
| APOC3  | AstraZeneca/CSPC         | YS2302018                     |            | oral small Molecule                                                      | Ph1                                                                                              |                                    |
| APOC3  | MSD/Hengrui              | HRS-5346                      |            | oral small Molecule                                                      | Ph1                                                                                              |                                    |
| APOC3  | Ionis/Akcea              | Volanesorsen                  | Waylivra   | ASO (LICA) targets APOC3                                                 | EMA: May 2019<br>FDA: issued CRL in Aug 2018                                                      |                                    |
| APOC3  | Ionis/Akcea              | olezarsen                     | Tryngolza  | ASO (GlaNAc) targets APOC4                                               | FDA: Dec 2024 / EMA: Sep 2025                                                                     |                                    |
| APOC3  | Arrowhead                | Plozasiran/普乐司兰钠          |            | GalNAc-conjugated siRNA                                                  | PDUFA 2025/11/18                                                                                  |                                    |
| APOC3  | Ribo Life Science 瑞博生物 | RBD5044                       |            | GalNAc-conjugated siRNA                                                  | 2024年10月开始Ph2                                                                                 |                                    |
| APOC3  | Rona Therapeutics 大睿生物 | RN0361                        |            | GalNAc-conjugated siRNA                                                  | Ph2                                                                                              |                                    |

资料来源：招商证券（香港），Evaluate Pharma，FDA<|end_of_box|>
收藏
行业数据
2025-11-20
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
全球竞争格局初现,RBD5044 进度第二。全球靶向 APOC3 的 siRNA 药物研发已形成初步竞争态势,目前共有 4 款候选药物处于临床开发阶段,尚无产品获批。其中Arrowhead 公司的普乐司兰(plozasiran)进度全球领先,已获批用于家族性乳糜微粒血症综合征(FCS),其针对更广泛 HTG 适应症的 III 期临床试验正在进行中;瑞博生物 RBD5044 是全球第二款进入临床的 APOC3 siRNA 药物,2024 年 10 月,RBD5044 获欧洲药品管理局(EMA)Ⅱ期临床试验许可在瑞典的混合型血脂异常患者中开展,2026 年 1 月 22 日获得国家药品监督管理局(NMPA)Ⅱ期临床试验默示许可在高甘油三酯血症患者中开展。
行业数据
原图定位
当前图表所属:
瑞博生物~B-6938.HK-港股公司研究报告:中国小核酸创新药领军者增长潜力大-260409(32页).pdf
财务报表预测摘要及指标
传统药物可成药蛋白数量很有限
主要小核酸药物特点对比
瑞博生物与Madrigal达成44亿美元重磅战略合作
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》